Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158925 · ClinicalTrials.gov registry record · NA
The EASYTRAK EPI Clinical Investigation
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00158925 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 100 participants.
The verdict
NCT00158925, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of the EASYTRAK EPI lead.
Interventions
- DEVICE EASYTRAK EPI lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158925
The ClinicalTrials.gov registry entry for NCT00158925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EASYTRAK EPI lead is the first listed.
NCT00158925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158925 about?
NCT00158925 is a clinical study titled "The EASYTRAK EPI Clinical Investigation". The purpose of this study is to assess the safety and effectiveness of the EASYTRAK EPI lead.
What is the current status of trial NCT00158925?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2004-09. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00158925?
The interventions under investigation include: EASYTRAK EPI lead (DEVICE).
Who is sponsoring clinical trial NCT00158925?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.